CDK5 and diabetes mellitus: The use of CDKs inhibitor and the overexpression of a dominant-negative CDK5 attenuates the loss of dopaminergic neurons, thus supporting the possible involvement of CDK5 in this pathology.475 CDK5 plays an important role in the progression of cognitive defects in diabetes.